Casey Hoyt - VIEMED HLTHCARE Chief Executive Officer, Director
| VIJ Stock | EUR 7.50 0.55 6.83% |
CEO
Casey Hoyt is Chief Executive Officer, Director of VIEMED HLTHCARE INC since 2016.
| Tenure | 8 years |
| Phone | 337 504 3802 |
| Web | http://www.viemed.com |
Casey Hoyt Latest Insider Activity
Tracking and analyzing the buying and selling activities of Casey Hoyt against VIEMED HLTHCARE stock is an integral part of due diligence when investing in VIEMED HLTHCARE. Casey Hoyt insider activity provides valuable insight into whether VIEMED HLTHCARE is net buyers or sellers over its current business cycle. Note, VIEMED HLTHCARE insiders must abide by specific rules, including filing SEC forms every time they buy or sell VIEMED HLTHCARE'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Casey Hoyt over six months ago Disposition of 26000 shares by Casey Hoyt of Viemed Healthcare subject to Rule 16b-3 |
VIEMED HLTHCARE Management Efficiency
The company has return on total asset (ROA) of 0.0436 % which means that it generated a profit of $0.0436 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0859 %, meaning that it generated $0.0859 on every $100 dollars invested by stockholders. VIEMED HLTHCARE's management efficiency ratios could be used to measure how well VIEMED HLTHCARE manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CEO Age | ||
| Jonathan Steinberg | WisdomTree Investments | 59 | |
Management Performance
| Return On Equity | 0.0859 | |||
| Return On Asset | 0.0436 |
VIEMED HLTHCARE INC Leadership Team
Elected by the shareholders, the VIEMED HLTHCARE's board of directors comprises two types of representatives: VIEMED HLTHCARE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VIEMED. The board's role is to monitor VIEMED HLTHCARE's management team and ensure that shareholders' interests are well served. VIEMED HLTHCARE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VIEMED HLTHCARE's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Frazier, Chief Medical Officer, Director | ||
| Jerome Cambre, Vice President of Sales | ||
| Bruce Greenstein, Independent Director | ||
| Timothy Smokoff, Independent Director | ||
| W Zehnder, Chief Operating Officer, Director | ||
| Casey Hoyt, Chief Executive Officer, Director | ||
| Nitin Kaushal, Independent Director | ||
| Randy Dobbs, Independent Chairman of the Board | ||
| Trae Fitzgerald, Chief Financial Officer | ||
| Sabrina Heltz, Director |
VIEMED Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is VIEMED HLTHCARE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0859 | |||
| Return On Asset | 0.0436 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.06 % | |||
| Shares Outstanding | 38.02 M | |||
| Shares Owned By Insiders | 11.85 % | |||
| Shares Owned By Institutions | 48.90 % | |||
| Price To Earning | 7.98 X | |||
| Revenue | 133.29 M | |||
| Gross Profit | 73.41 M |
Currently Active Assets on Macroaxis
Other Information on Investing in VIEMED Stock
VIEMED HLTHCARE financial ratios help investors to determine whether VIEMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VIEMED with respect to the benefits of owning VIEMED HLTHCARE security.